Actithera
- | Biotech or pharma, therapeutic R&D
Actithera is an early-stage Radiotherapeutics company focusing on the discovery of best-in-class small molecule and peptide-based radiotherapeutics. We have a unique platform for the design of radioconjugates with prolonged retention in tumors. This platform has three pillars, including a major approach that leverages covalency. The platform has resulted in a best-in-class FAP-directed development candidate with Pluvicto-like PK profile. We are syndicating around a term sheet from a sophisticated investor with experience in RLT to raise $50M to bring our DC to patients within the next 6 months and apply our platform on several additional important theranostic targets.
Address
CambridgeMA
United States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}